BIOMAT Database Logo BIOMAT Database Logo

Synthesis and hypoglycemic activity of 7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives and related compounds. 1986

S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011714 Pyrans Pyran
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent.
April 1986, Archives internationales de pharmacodynamie et de therapie,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors.
February 2014, Bioorganic & medicinal chemistry letters,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold.
October 2017, Molecules (Basel, Switzerland),
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives bearing chromone moiety.
August 2016, Bioorganic & medicinal chemistry,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.
December 2014, Bioorganic & medicinal chemistry,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Synthesis and Biological Evaluation of Novel 4-Morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine Derivatives Bearing Phenylpyridine/ Phenylpyrimidine-Carboxamides.
October 2016, Molecules (Basel, Switzerland),
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent.
January 1989, Archives internationales de pharmacodynamie et de therapie,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Synthesis and antitumor activity of isolongifoleno[7,8-d]thiazolo[3,2-a]pyrimidine derivatives via enhancing ROS level.
August 2019, Chemical biology & drug design,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
[Antibacterial activity of pyrimidine and pyrrolo-(3,2-d)-pyrimidine derivatives].
July 1972, Farmakologiia i toksikologiia,
S Ohno, and K Mizukoshi, and O Komatsu, and Y Kunoh, and Y Nakamura, and E Katoh, and M Nagasaka
Synthesis of (1)benzothieno(3,2-d)pyrimidine derivatives.
July 1973, The Journal of organic chemistry,
Copied contents to your clipboard!